Inhibitor Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Inhibitor Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2012 to Q3 2024.
  • Inhibitor Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$731K, a 9.96% decline year-over-year.
  • Inhibitor Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$3.08M, a 129% decline year-over-year.
  • Inhibitor Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.03M, a 125% decline from 2022.
  • Inhibitor Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $12.1M.
  • Inhibitor Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$299K, a 71.8% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.08M -$731K -$66.2K -9.96% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$3.02M -$502K +$153K +23.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$3.17M -$685K -$145K -26.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$3.03M -$1.17M -$13.5M -109% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $10.5M -$665K -$587K -756% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $11.1M -$655K -$577K -744% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 $11.7M -$540K -$441K -446% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 $12.1M $12.4M +$12.4M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$288K -$77.7K -$6.64K -9.35% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$281K -$77.6K -$11.4K -17.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$270K -$98.9K +$28.9K +22.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$299K -$33.6K +$22.3K +39.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$321K -$71.1K +$232K +76.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$553K -$66.2K +$249K +79% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$801K -$128K +$257K +66.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$1.06M -$55.9K +$580K +91.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$1.64M -$303K +$376K +55.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$2.01M -$315K +$318K +50.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$2.33M -$384K +$402K +51.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$2.73M -$636K +$690K +52.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 -$3.42M -$679K +$493K +42.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$3.92M -$633K +$249K +28.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-16
Q1 2019 -$4.17M -$786K +$384K +32.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-16
Q4 2018 -$4.55M -$1.33M -$422K -46.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$4.13M -$1.17M -$492K -72.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$3.64M -$882K -$165K -23.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-07
Q1 2018 -$3.47M -$1.17M +$1.63M +58.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-07
Q4 2017 -$5.1M -$904K +$1.85M +67.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$6.95M -$679K +$1.05M +60.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$7.99M -$716K +$613K +46.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-23
Q1 2017 -$8.61M -$2.8M -$1.61M -135% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 -$7M -$2.75M -$1.72M -166% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-16
Q3 2016 -$5.28M -$1.73M -$523K -43.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 -$4.76M -$1.33M -$537K -67.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-31
Q1 2016 -$4.22M -$1.19M -$272K -29.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$3.95M -$1.03M -$135K -15% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-17
Q3 2015 -$3.81M -$1.2M -$462K -62.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-31
Q2 2015 -$3.35M -$792K +$1.35M +63% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$4.7M -$923K -$726K -370% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$3.98M -$898K -$683K -317% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-01
Q3 2014 -$3.29M -$740K +$552K +42.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$3.84M -$2.14M -$1.87M -702% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-13
Q1 2014 -$1.97M -$196K -$136K -225% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$1.84M -$215K Oct 1, 2013 Dec 31, 2013 10-K 2015-02-13
Q3 2013 -$1.29M -$1.93M -302% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-10
Q2 2013 -$267K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$60.5K Jan 5, 2013 Mar 31, 2013 10-Q 2014-05-12
Q3 2012 $640K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.